Validation of OraQuick HCV Rapid Antibody Test in Postmortem Specimens | Zendy

Claire E. Rose | Zendy; Lisa Duncan | Zendy; Amy Hawes | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Validation of OraQuick HCV Rapid Antibody Test in Postmortem Specimens

Author(s) -

Claire E. Rose,

Lisa Duncan,

Amy Hawes

Publication year - 2020

Publication title -

academic forensic pathology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.256

H-Index - 11

ISSN - 1925-3621

DOI - 10.1177/1925362120957521

Subject(s) - medicine , immunoassay , gold standard (test) , antibody , hepatitis c , hepatitis c virus , immunology , virus

The objective of this study is to evaluate the performance of OraQuick HCV Rapid Antibody Test against a "gold-standard", FDA-approved, laboratory-based serum immunoassay (SI) in postmortem blood. To date, OraQuick HCV Rapid Antibody Test has not been evaluated for use in postmortem testing. This OraQuick test is a manually performed, visually interpreted, single use immunoassay for the qualitative detection of antibodies to the hepatitis C virus (HCV).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research